Steady development and strong growth
In 2001, zhejiang kangtai group acquired wuhan pharmaceutical factory branch, which had been closed for many years.
In 2002, the factory was gradually improved.
In 2004 under the national implementation of the rise of central China policy, then the zhejiang provincial party secretary xi jinping, governor Luo Qingquan personally meet with chairman of the board of directors of the company in hebei province Chen Tianzhong and pose, gave nameboards in wuhan, was established in hubei enterprises association, zhejiang province, put together in hubei investment of zhejiang enterprises, contribute to further strengthen the rise of central China. This is by far the most senior and largest provincial government federation.
With the attention of the two governments, the company implemented the investment expansion strategy in hubei in the same year. Collect land, build new standardized factories, introduce advanced equipment and testing instruments to carry out the comprehensive reconstruction of the new factory area: namely the expansion of the factory, the reconstruction of the factory area, the introduction of production lines, personnel placement and other comprehensive work, and achieve excellent results. In the same year, ten thousand workshop and ten thousand workshop passed the GMP acceptance and certification. This is a very important milestone in the development history of kangzheng pharmaceutical, marking a new step for the company.
In 2005, in order to adapt to the market and keep pace with The Times, the company cooperated with tongji hospital, college of traditional Chinese medicine, Peking University medical college, zhejiang medical college and other famous domestic institutions of higher learning and many scientific research institutes to develop new products.
In 2006, the company expanded its sales network in the domestic market and established a national sales network.
In 2007, the company invested heavily in a systematic transformation from hardware to software to make the enterprise more modern.
In 2008, we further improved the domestic marketing network and set up offices in various regions.
In 2010, the company entered the overseas market, and selected the internationally competitive varieties to promote to the international market, and gradually exported high-quality drugs overseas. And successfully developed the international market, sold overseas. That is, southeast Asia, Africa sixteen francophones countries and Latin America、 Europe, and in southeast Asia, Africa sixteen francophones countries registered kangzheng brand, and obtained a good reputation. The products cover more than 30 countries and regions.
From 2011 to 2012, it was listed in the export recommendation catalogue of Chinese competitive medicine and export list of Chinese regular enterprises by China's medical insurance affiliated to the ministry of commerce.
In 2016, it passed the new GMP certification.
Since its establishment, the company has invested a lot of manpower, financial resources and material resources, as well as the introduction of modern management mode.Has developed into a domestic dosage form of the best quality、 the most complete variety、 the best price of professional external drug production enterprises.
